发明名称 Surface exposed <i>Haemophilus influenzae </i>protein (protein; pE)
摘要 The present invention relates to a surface exposed protein (protein E; pE), a virulence factor, which can be detected in Haemophilus influenzae, having an amino acid sequence as described in SEQ ID NO: 1, an immunogenic fragment of said surface exposed protein, and a recombinant immunogenic protein (pE (A)) or truncated variants thereof based on said surface exposed protein. Nucleic acid sequences, vaccines, plasmids and phages, non human hosts, recombinant nucleic acid sequences, fusion proteins and fusion products are also described. A method of producing the said protein or truncated fragments thereof recombinantly is also disclosed.
申请公布号 US9309293(B2) 申请公布日期 2016.04.12
申请号 US201314109573 申请日期 2013.12.17
申请人 ARNE FORSGREN ET AL 发明人 Forsgren Arne;Riesbeck Kristian
分类号 A61K39/02;A61K48/00;C12Q1/68;C12P21/06;C07K14/235;C12N15/74;C07K14/285;A61K39/00 主分类号 A61K39/02
代理机构 Finnegan, Henderson, Farabow, Garrett & Dunner LLP 代理人 Finnegan, Henderson, Farabow, Garrett & Dunner LLP
主权项 1. An immunogenic composition comprising an isolated polypeptide, wherein the polypeptide comprises an amino acid sequence that varies from SEQ ID NO:1 in at least three positions, wherein the variation(s) are selected from the group consisting of a deletion of a signal peptide (amino acids 1-20) of SEQ ID NO:1, a Thr substitution of Ile at position 20 of SEQ ID NO:1, a Val substitution of Ala at position 23 of SEQ ID NO:1, a Glu substitution of Lys at position 24 of SEQ ID NO:1, a Met substitution of Val at position 28 of SEQ ID NO:1, a Thr substitution of Ala at position 31 of SEQ ID NO:1, a Val substitution of Ile at position 41 of SEQ ID NO:1, an Ala substitution of Val at position 47 of SEQ ID NO:1, a Lys substitution of Arg at position 76 of SEQ ID NO:1, a Val substitution of Ile at position 107 of SEQ ID NO:1, a Lys substitution of Gly at position 152 of SEQ ID NO:1, a Val substitution of Ala at position 154 of SEQ ID NO:1, a Ser-Ala-Pro addition at the C-terminus of SEQ ID NO:1, a Val substitution of Pro at position 32 of SEQ ID NO:1, and an Ala substitution of Pro at position 32 of SEQ ID NO:1, wherein the composition further comprises an immunogenic portion of an outer membrane protein of a respiratory tract pathogen.
地址 Falsterbo SE